Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)

Lipoprotein(a) [Lp(a)] is a well-established risk factor for cardiovascular disease, predisposing to major cardiovascular events, including coronary heart disease, stroke, aortic valve calcification and abdominal aortic aneurysm. Lp(a) is differentiated from other lipoprotein molecules through apoli...

Full description

Bibliographic Details
Main Authors: Constantine E. Kosmas, Maria D. Bousvarou, Evangelia J. Papakonstantinou, Donatos Tsamoulis, Andreas Koulopoulos, Rogers Echavarria Uceta, Eliscer Guzman, Loukianos S. Rallidis
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
lipoprotein(a)
hyperlipoproteinemia(a)
cardiovascular disease
antisense oligonucleotides
pelacarsen
small interfering RNAs
Online Access:https://www.mdpi.com/1422-0067/24/17/13622

Internet

https://www.mdpi.com/1422-0067/24/17/13622

Similar Items